Showing results (931-940 of 1,024) with videos related to
Sort By:
Pageof 103
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 3, 2025
Xevinapant or Placebo Plus Platinum-Based Chemoradiotherapy in Unresected Locally Advanced Squamous Cell Carcinoma of the Head and Neck (TrilynX): A Randomized, Phase III StudyJean Bourhis, Lisa F Licitra, Barbara Burtness, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 29, 2012
A phase II study of lapatinib in recurrent/metastatic squamous cell carcinoma of the head and neckJonas A de Souza, Darren W Davis, Yujian Zhang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2011
Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancerRazelle Kurzrock, Steven I Sherman, Douglas W Ball, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2013
Cabozantinib in progressive medullary thyroid cancerRossella Elisei, Martin J Schlumberger, Stefan P Müller, et al.The Lancet. Oncology|May 14, 2021
Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trialAssuntina G Sacco, Ruifeng Chen, Francis P Worden, et al.JAMA Oncology|May 1, 2018
Multiple Myeloma and Its Precursor Disease Among Firefighters Exposed to the World Trade Center DisasterOla Landgren, Rachel Zeig-Owens, Orsolya Giricz, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 18, 2016
Response-adapted volume de-escalation (RAVD) in locally advanced head and neck cancerV M Villaflor, J M Melotek, T G Karrison, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 11, 2019
Afatinib versus methotrexate as second-line treatment in Asian patients with recurrent or metastatic squamous cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 3): an open-label, randomised phase III trialY Guo, M-J Ahn, A Chan, et al.Science (New York, N.Y.)|March 26, 2021
mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infectionLeonidas Stamatatos, Julie Czartoski, Yu-Hsin Wan, et al.Journal of Oncology Practice|May 2, 2012
Patterns of care for non-small-cell lung cancer at an academic institution affiliated with a national cancer institute-designated cancer centerKim-Son H Nguyen, Rachel A Sanford, Mark S Huberman, et al.Pageof 103